---
title: "Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A"
ocid: "ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "THE ROYAL MARSDEN NHS FOUNDATION TRUSTS"
published: "2019-05-31"
---

# Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A

Buyer: THE ROYAL MARSDEN NHS FOUNDATION TRUSTS  
Current stage: Award  
OCID: ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559.json)

## Summary

The Royal Marsden NHS Foundation Trusts is conducting a procurement process for the purchase of ANMI PSMA Setrile 360 vials and ANMI Elution Tools Gen A, specifically aimed at treating prostate cancer. This procurement is classified under the industry category of reagents and contrast media, with a total contract value of £2,000,000. The procurement method utilised is classified as 'Other', and the contract period will commence on 1st June 2019 and runs until 30th May 2021. The tender period closed on 26th May 2019, and the contract is primarily set to be delivered in London, United Kingdom.

This tender represents a significant opportunity for businesses specialising in medical supplies, pharmaceuticals, and imaging technologies, particularly those with capabilities in radiopharmaceutical production and distribution. Companies that can provide high-quality reagents and meet the specific requirements of the NHS, particularly in relation to prostate cancer diagnostics, would be well-positioned to compete. The active engagement of a reputable buyer like The Royal Marsden NHS Foundation Trusts further enhances the potential for business growth in this niche market.

## Notice

The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available treatment as effective are available on the NHS - Ga-68 PSMA scan can be used in PET imaging. PET imaging provides greater resolution and speed of imaging and therefore diagnosis of prostate cancer. PSMA (Prostate Specific Membrane Antigens) are over expressed on Prostate Tumours and therefore, by targeting and Imaging them with Radiopharmaceutical compounds, enables clinicians to better diagnose and manage patient's recurrent prostate cancer disease. There is currently no Marketing Authorisation for this product. The HBEDCC-11 kit Peptide, from ANMI, is the most widely available and popular choice at this time, that efficiently labels with Ga68 and provides high quality and accurate diagnosis of Prostate PSMA. The Royal Marsden Radiopharmacy already operates an efficient Ga68 Generator and therefore, is capable of combining with this HBEDCC-11 peptide from ANMI. Use of Ga-68 generator enables production of Ga-68 PSMA on-site allowing flexibility of service and negates reliance on outsourced companies for delivery radiopharmaceuticlals Curium is the official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/2799a347-dbb9-4d51-884f-1b85f00895c5 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Other - |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 31 May 2019 |
| Submission deadline | 26 May 2019 |
| Future notice date | Not specified |
| Award date | 30 May 2019 |
| Contract period | 31 May 2019 - 30 May 2021 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £2,000,000 |
| Lots value | Not specified |
| Awards value | £2,200,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE ROYAL MARSDEN NHS FOUNDATION TRUSTS |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW10 0XD |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI33 Kensington & Chelsea and Hammersmith & Fulham |
| Local authority | Hammersmith and Fulham |
| Electoral ward | Sands End |
| Westminster constituency | Chelsea and Fulham |
| Delivery location | TLI London |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | CURIUM PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696000 - Reagents and contrast media

## Release History

- 31 May 2019 at 13:10 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/2799a347-dbb9-4d51-884f-1b85f00895c5

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/2799a347-dbb9-4d51-884f-1b85f00895c5
  31st May 2019 - Awarded contract notice on Contracts Finder

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559.json.